Neurological Disorders

Five things for pharma marketers to know: Wednesday, September 2, 2015

Five things for pharma marketers to know: Wednesday, September 2, 2015

By

Novartis and Amgen form neuroscience collaboration; the FDA approves a drug for people undergoing chemotherapy; a judge considers denying Pfizer's request to toss federal lawsuit

More than 400 drugs in development for neurological disorders

PhRMA and the Epilepsy Foundation said 50-million Americans are affected by disorders such as Alzheimer's disease and multiple sclerosis.

OPINION

Email Newsletters